Skip to main content
    N

    Neurocrine Biosciences Inc (NBIX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $165.92
    +0.61 (+0.37%)

    Market Cap: $16.73B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Neurocrine Biosciences Inc (NBIX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Neurocrine Biosciences (NBIX) has a latest price of $165.92 on Nov 17, 2026, 10.9% below its 52-week high of $186.12. Its price rose 14.5% over the past 12 months. The month-end price rose 233.8% over the 10 years through Oct 2026, a compound annual rate of 12.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $168.53 in Jun 2026 and its lowest $38.70 in Dec 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NBIX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NBIX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 6.7%, and over 6 months it rose 7.5%. The month-end price rose 31.7% over the 3 years through Oct 2026, a compound annual rate of 9.6%.

    PeriodChange
    1 month+21.1%
    3 months+6.7%
    6 months+7.5%
    12 months+14.5%
    12 months, with dividends+14.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+31.7%+9.6%
    5 years+38.6%+6.7%
    10 years+233.8%+12.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 100.5%, and its weakest was 2021, when it fell 11.1%.

    YearCloseChange
    2026 through Oct 2026$146.10+3.0%
    2025$141.83+3.9%
    2024$136.50+3.6%
    2023$131.76+10.3%
    2022$119.44+40.2%
    2021$85.17-11.1%
    2020$95.85-10.8%
    2019$107.49+50.5%
    2018$71.41-8.0%
    2017$77.59+100.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 11.4% above its 50-day average of $148.99 and 11.2% above its 200-day average of $149.17.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$165.92
    52-week high$186.12-10.9%
    52-week low$122.14+35.8%
    50-day average$148.99+11.4%
    200-day average$149.17+11.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 42.9%.

    MeasureValue
    1-year beta0.67
    Largest fall, 1 year-27.2%
    Largest fall, 3 years-42.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Neurocrine Biosciences traded at 22.2x earnings at the end of 2025, against a 5-year median of 24.7x.

    NBIX valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NBIX

    What is NBIX's 1-year price change?

    Neurocrine Biosciences's price rose 14.5% over the past 12 months. With dividends included, the 12-month total return was 14.5%.

    What is NBIX's 5-year price change?

    Neurocrine Biosciences's month-end price rose 38.6% over the 5 years through Oct 2026, a compound annual rate of 6.7%. These figures leave out dividends.

    What is NBIX's 52-week high and low?

    Neurocrine Biosciences's 52-week high is $186.12 and its 52-week low is $122.14. Its latest price of $165.92 on Nov 17, 2026 is 10.9% below the high.

    What is NBIX's beta?

    Neurocrine Biosciences's 1-year beta against the S&P 500 is 0.67, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 27.2%.

    Is the NBIX chart free?

    Yes. Advanced Charting for NBIX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.